RNA at the Bench and Bedside V

The conference will discuss the development of nucleic acid medicines including recent clinical successes, and current and upcoming challenges. By bringing together academics in basic and translational research and their peers in thriving biotechnology companies and promising start-ups, the conference aims to foster dialogue and to spearhead collaborations. The first day (December 8th) will discuss basic RNA biology and upcoming computational and AI methods, along with a panel discussion. The second day will cover translational nucleic acid gene therapies. There will also be a meet-the-editor session with journal editors. The 3rd and final day will cover clinical advances in therapeutics and end at noon.